Sagent Pharmaceuticals recalls MethylPREDNISolone Acetate Injectable Suspension
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Presence of Particulate Matter: Potential for black particulates in the drug product.
- Products
-
- MethylPREDNISolone Acetate Injectable Suspension
- Company
- Sagent Pharmaceuticals
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 14,360 vials
- About this recall
- MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-Dose Vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195, Made in India. NDC: 25021-820-10